What counseling should I provide to a healthy 40‑year‑old woman about why combined estrogen‑progestin contraception is not recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Combined Contraceptives Are Not Recommended at Age 40

Age 40 alone does not automatically disqualify a healthy woman from using combined hormonal contraceptives, but the decision requires careful assessment of cardiovascular risk factors that become increasingly important at this age. 1

Key Cardiovascular Risk Assessment

The primary concern with combined estrogen-progestin contraceptives in women aged 40 and older centers on increased risk of venous thromboembolism, myocardial infarction, and stroke—risks that escalate with age even in otherwise healthy women. 1

Critical Risk Factors to Discuss:

  • Smoking status: Women aged ≥35 years who smoke ≥15 cigarettes per day face unacceptable health risks (Category 4) and should absolutely not use combined contraceptives due to dramatically elevated risk of myocardial infarction and stroke. 1 Even smoking <15 cigarettes per day at age ≥35 makes combined contraceptives usually not recommended (Category 3). 1

  • Hypertension: Any degree of elevated blood pressure increases cardiovascular risk when combined with estrogen-containing contraceptives. 2, 3

  • Thromboembolism risk: The baseline risk of venous thromboembolism in healthy women taking combined contraceptives is 36 times higher than the baseline annual risk, and this multiplier applies to an already higher baseline risk at age 40+. 1

  • Migraine with aura: This represents an absolute contraindication to estrogen-containing contraceptives at any age due to stroke risk. 2

Age-Related Cardiovascular Evidence

Studies demonstrate that the incidence of venous thromboembolism was higher among oral contraceptive users aged ≥45 years compared with younger users, though the interaction between hormonal contraception and increased age was not definitively demonstrated. 1 The relative risk for myocardial infarction was higher among all oral contraceptive users than nonusers, without a clear trend of increased relative risk with increasing age. 1

Small but measurable increased risks for breast cancer exist among women aged ≥45 years whose last use of combined hormonal contraceptives was within the previous 5-9 years. 1

Safer Alternatives to Recommend

Highly Effective Options (Pregnancy rate <1% per year):

  • Levonorgestrel or copper IUDs: No increased thrombosis risk, highly effective, and appropriate for women over 40. 1

  • Progestin-only pills: Relative risk for VTE is 0.90 (95% CI 0.57-1.45), making them substantially safer than combined methods. 1

  • Subdermal progestin implant: Highly effective with no estrogen-related cardiovascular risks. 1

Important Counseling Point:

Women aged >45 years can use progestin-only pills, implants, levonorgestrel IUDs, or copper IUDs without age-related restrictions (Category 1), while combined hormonal contraceptives and DMPA are Category 2 (generally can be used but require careful follow-up). 1 However, any chronic conditions or risk factors may render hormonal contraceptive methods unsafe, necessitating individualized assessment. 1

Pregnancy Risk Context

Emphasize that pregnancy at age 40+ carries substantial risks: maternal complications including hemorrhage, venous thromboembolism, and death, plus fetal complications such as spontaneous abortion, stillbirth, and congenital anomalies. 1 The median age of definitive loss of natural fertility is 41 years but can range up to age 51 years, so effective contraception remains essential. 1

Common Clinical Pitfall

Research shows that 39% of women with medical contraindications to estrogen-containing contraceptives still use combined hormonal contraceptives—a rate not statistically different from women without contraindications. 2 This represents a significant patient safety issue that requires proactive screening and counseling about safer alternatives.

Practical Counseling Framework

When a 40-year-old woman requests combined contraceptives:

  1. Screen for absolute contraindications: smoking status, blood pressure, history of VTE/stroke/cardiovascular disease, migraine with aura, breast cancer, liver disease. 1, 2, 3

  2. If any contraindication exists: Strongly recommend progestin-only methods or IUDs as safer, equally effective alternatives. 1

  3. If no contraindications present: Combined contraceptives may be used (Category 2) but require careful follow-up and blood pressure monitoring at 3 months. 1

  4. Emphasize that contraception should continue until age 50-55 years (median menopause age ~51 years), as no reliable laboratory tests confirm definitive loss of fertility. 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended protocol for initiating contraception in a reproductive‑aged woman, including screening for estrogen contraindications and selecting an appropriate method?
What alternative combined oral contraceptives (COCs) can be considered for a female patient of reproductive age with a history of using hormonal methods, who may have conditions such as thromboembolic events, hypertension, or migraine with aura?
Can a 55-year-old woman stop taking combined oral contraceptives (COCs)?
Is combined hormonal contraception contraindicated in women with World Health Organization Medical Eligibility Criterion (MEC) category 4 conditions?
Who should not take combination (combo) birth control pills?
What are examples of progestin‑only pills for a healthy 40‑year‑old woman with no contraindications?
What are the ingredients in the Neuriva dietary supplement?
What is the appropriate hydrocortisone dose for an adult patient?
What is the most likely diagnosis and recommended treatment for a 35‑year‑old woman with a 4‑month history of intermittent facial erythema on the cheeks and no alcohol use?
What oral iron‑folic acid dose should be given to a female with hemoglobin 9.4 g/dL, and what vitamin D dose for a 25‑hydroxyvitamin D level of 9 ng/mL, including recommended brands?
When can bronchopneumonia be diagnosed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question